Showing results (1701-1710 of 2,184) with videos related to
Sort By:
Pageof 219
Kidney Cancer (Clifton, Va.)|October 11, 2021
Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United StatesLauren E Wilson, Lisa Spees, Jessica Pritchard, et al.BMC Medical Informatics and Decision Making|June 23, 2021
Key changes to improve social presence of a virtual health assistant promoting colorectal cancer screening informed by a technology acceptance modelMelissa J Vilaro, Danyell S Wilson-Howard, Mohan S Zalake, et al.Nature Materials|September 15, 2015
Conductivity in organic semiconductors hybridized with the vacuum fieldE Orgiu, J George, J A Hutchison, et al.Current Medical Research and Opinion|August 9, 2014
Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: synthesis of findings from two multi-practice chart reviews in the United StatesJames E Signorovitch, Nicholas J Vogelzang, Sumanta K Pal, et al.Radiology|August 9, 2013
Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic successCharles E Spritzer, P Diana Afonso, Emily N Vinson, et al.British Journal of Cancer|February 20, 2014
RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomasS Deb, H Xu, J Tuynman, et al.Urologic Oncology|July 23, 2019
Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancerJason Zhu, Matthew Tucker, Daniele Marin, et al.Expert Opinion on Pharmacotherapy|March 14, 2015
Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United StatesMichael K Wong, Eric Jonasch, Sumanta K Pal, et al.Genome Research|January 30, 2010
ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cellsLee H Wong, James D McGhie, Marcus Sim, et al.European Urology Oncology|December 24, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO StudyRonald Tutrone, Fred Saad, Daniel J George, et al.Pageof 219